News archive

Read the latest news from the nanomedicine world.

We are thrilled to announce the launch of our new video series, “We Are ETPN!” dedicated to highlighting the brilliant minds and groundbreaking work within the European Technology Platform on Nanomedicine (ETPN) community. In our first episode, we feature NanoVation Therapeutics™, a leader in nucleic acid delivery and RNA therapeutics. This series aims to give our members a platform to share their inspiring stories and innovative solutions that are shaping the future of healthcare.

Watch the First Episode Now: NanoVation Therapeutics Joins ETPN

Episode Overview

In this exclusive interview, Dominik Witzigmann, PhD, co-founder and CEO of NanoVation Therapeutics, delves into the pioneering work his team is doing in the realm of nano-enabled gene therapy. Discover how their advanced Long Circulating LNP technology are revolutionizing future patient care byovercoming the challenges of nucleic acid delivery.

Episode Highlights:

  • 00:00 – Introduction
  • 00:07 – Empowering Gene Therapy
  • 00:17 – The Delivery Challenge
  • 00:25 – Next Generation Lipid Nanoparticles
  • 00:35 – Why We Join The ETPN

Featured Quote: “Science is too complicated to work in silos; at NanoVation, we thrive by connecting dots across the entire value chain of healthcare innovations. We are NanoVation Therapeutics. We are ETPN!” – Dominik Witzigmann

About NanoVation Therapeutics™ (NTx)

 

NanoVation Therapeutics™ develops customized nucleic acid and lipid nanoparticle technologies to empower its partners’ genetic medicines. By enabling the safe and efficacious delivery of nucleic acids to a variety of tissues, NTx’s unique toolbox can rapidly advance therapeutic concepts into clinical reality. Learn more about NanoVation Therapeutics

About ETPN:

The European Technology Platform on Nanomedicine (ETPN) is a dynamic alliance fostering research, development, and clinical integration of cutting-edge nanotechnology innovations in healthcare. As Europe’s leading nanomedicine think tank, ETPN collaborates with over 120 entities to propel technological advancements and streamline clinical applications, ensuring that tomorrow’s solutions reach patients efficiently. Learn more about ETPN

Connecting Our Community:

The “We Are ETPN!” series is designed to connect our members and the broader scientific community, highlighting the collaborative efforts and breakthroughs that define our network. Each episode will delve into the innovative solutions and passionate individuals driving progress in nanomedicine.

Engage with Us:

We invite you to join us on this exciting journey by watching, liking, commenting, and sharing each episode. Your engagement helps amplify the impact of our community’s work and fosters a stronger connection within the network.

Stay Tuned for More:

Stay tuned for more episodes as we continue to showcase the incredible work being done by our members.
Not yet a member? Join us and be part of shaping the future of nanomedicine and healthcare innovation in Europe!

Join ETPN: Interested in becoming a member of ETPN? Learn more about our membership benefits and how to join.

Together: We Are ETPN! Let’s continue to drive innovation and make a lasting impact on healthcare.


Social Media Links:

Follow us on LinkedIn and Twitter for more updates.

Tags: #WeAreETPN, #Nanomedicine, #HealthcareInnovation, #RNATherapeutics, #NucleicAcids, #LongCirculatingLNP, #ETPN2024